Inhibition of human organic anion transporting polypeptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemia.

OATP1B1 (a.k.a. OATP-C, OATP2, LST-1, or SLC21A6) is a liver-specific organic anion uptake transporter and has been shown to be a higher affinity bilirubin uptake transporter than OATP1B3. Using human embryonic kidney (HEK 293) cells stably transfected with OATP1B1, we have studied the effects of indinavir, saquinavir, cyclosporin A, and rifamycin SV on human OATP1B1 transport function. These drugs are potent inhibitors of OATP1B1 transport activity in vitro. We further provide evidence that the calculated fraction of OATP1B1 inhibited at the clinical exposure level correlated very well with the observed hyperbilirubinemia outcome for these drugs in humans. Our data support the hypothesis that inhibition of OATP1B1 is an important mechanism for drug-induced unconjugated hyperbilirubinemia. Inhibition of OATPs may be an important mechanism in drug-drug and drug-endogenous substance interactions.

[1]  B. Scharschmidt,et al.  Abnormal hepatic transport of indocyanine green in Gilbert's syndrome. , 1976, Gastroenterology.

[2]  D. Keppler,et al.  Hepatic Uptake of Bilirubin and Its Conjugates by the Human Organic Anion Transporter SLC21A6* , 2001, The Journal of Biological Chemistry.

[3]  J. Ostrow,et al.  Uptake of [3H]bilirubin in freshly isolated rat hepatocytes: role of free bilirubin concentration , 1999, FEBS letters.

[4]  V. Sasseville,et al.  A Novel Human Hepatic Organic Anion Transporting Polypeptide (OATP2) , 1999, The Journal of Biological Chemistry.

[5]  J. Nezu,et al.  Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. , 2000, Biochemical and biophysical research communications.

[6]  M. Clozel,et al.  Inhibition of Organic Anion Transporting Polypeptide-Mediated Hepatic Uptake Is the Major Determinant in the Pharmacokinetic Interaction between Bosentan and Cyclosporin A in the Rat , 2004, Journal of Pharmacology and Experimental Therapeutics.

[7]  Impaired plasma clearance of nicotinic acid and rifamycin-SV in Gilbert's syndrome: evidence of a functional heterogeneity. , 1985, Hepato-gastroenterology.

[8]  Peter J. Meier,et al.  Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties , 2004, Pflügers Archiv.

[9]  D. Keppler,et al.  Hepatic Secretion of Conjugated Drugs and Endogenous Substances , 2000, Seminars in liver disease.

[10]  J. Angel,et al.  Hepatotoxicity associated with antiretroviral therapy containing dual versus single protease inhibitors in individuals coinfected with hepatitis C virus and human immunodeficiency virus. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  D. Keppler,et al.  Export pumps for anionic conjugates encoded by MRP genes. , 1999, Advances in enzyme regulation.

[12]  E. Gabazza,et al.  Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance , 2000, Journal of Gastroenterology.

[13]  G. Acocella,et al.  The effect of an intravenous infusion of rifamycin SV on the excretion of bilirubin, bromsulphalein, and indocyanine green in man. , 1965, Gastroenterology.

[14]  P. Meier,et al.  The peptide‐based thrombin inhibitor CRC 220 is a new substrate of the basolateral rat liver organic anion‐transporting polypeptide , 1996, Hepatology.

[15]  R. Kim,et al.  Human Organic Anion Transporting Polypeptide-C (SLC21A6) Is a Major Determinant of Rifampin-Mediated Pregnane X Receptor Activation , 2003, Journal of Pharmacology and Experimental Therapeutics.

[16]  P. Dawson,et al.  Fruit juices inhibit organic anion transporting polypeptide–mediated drug uptake to decrease the oral availability of fexofenadine , 2002, Clinical pharmacology and therapeutics.

[17]  C. Tiribelli,et al.  The implication of bilitranslocase function in the impaired rifamycin SV metabolism in Gilbert's syndrome. , 1985, Clinical science.

[18]  P. Morlat,et al.  The absence of hyperbilirubinaemia is highly predictive of treatment failure in advanced HIV-infected patients treated with indinavir , 2001, International journal of STD & AIDS.

[19]  R. Kim,et al.  The Human Organic Anion Transport Protein SLC21A6 Is Not Sufficient for Bilirubin Transport* , 2003, Journal of Biological Chemistry.

[20]  T. Cantz,et al.  MRP2, a human conjugate export pump, is present and transports fluo 3 into apical vacuoles of Hep G2 cells. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[21]  G. Lockitch,et al.  Age- and sex-specific pediatric reference intervals for biochemistry analytes as measured with the Ektachem-700 analyzer. , 1988, Clinical chemistry.

[22]  D. Keppler,et al.  A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[23]  R. Guillet,et al.  Bilirubin and Serial Auditory Brainstem Responses in Premature Infants , 2001, Pediatrics.

[24]  T. Abe,et al.  Human liver-specific organic anion transporter, LST-1, mediates uptake of pravastatin by human hepatocytes. , 2001, The Journal of pharmacology and experimental therapeutics.

[25]  S. Piscitelli,et al.  Protease inhibitors for the treatment of human immunodeficiency virus infection. , 1998, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[26]  Yuichi Sugiyama,et al.  Drug-Drug Interactions Involving the Membrane Transport Process , 2001 .

[27]  R. Kim,et al.  Polymorphisms in OATP-C , 2001, The Journal of Biological Chemistry.

[28]  J. González‐Gallego,et al.  Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin. , 2003, The Biochemical journal.

[29]  S. Vavricka,et al.  Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver , 2002, Hepatology.

[30]  T. Futami,et al.  Organic Anion Transporter oatp2-Mediated Interaction between Digoxin and Amiodarone in the Rat Liver , 2002, Pharmaceutical Research.

[31]  J. Dong,et al.  Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. D. Rodrigues,et al.  Drug-drug interactions , 2001, Atkinson's Principles of Clinical Pharmacology.

[33]  Yunhai Cui,et al.  Influence of albumin binding on the substrate transport mediated by human hepatocyte transporters OATP2 and OATP8 , 2003, Journal of Gastroenterology.

[34]  F. Follath,et al.  HYPERBILIRUBINAEMIA AND CYCLOSPORIN A LEVELS IN RENAL TRANSPLANT PATIENTS , 1981, The Lancet.

[35]  T. Abe,et al.  Transcellular Transport of Organic Anions Across a Double-transfected Madin-Darby Canine Kidney II Cell Monolayer Expressing Both Human Organic Anion-transporting Polypeptide (OATP2/SLC21A6) and Multidrug Resistance-associated Protein 2 (MRP2/ABCC2)* , 2002, The Journal of Biological Chemistry.

[36]  Yuichi Sugiyama,et al.  Inhibition of Transporter-Mediated Hepatic Uptake as a Mechanism for Drug-Drug Interaction between Cerivastatin and Cyclosporin A , 2003, Journal of Pharmacology and Experimental Therapeutics.

[37]  D. Keppler,et al.  A Naturally Occurring Mutation in the SLC21A6Gene Causing Impaired Membrane Localization of the Hepatocyte Uptake Transporter* , 2002, The Journal of Biological Chemistry.

[38]  B. Kjessler.  HORMONES AND LACTATION. , 1964, Lancet.

[39]  D. Meijer,et al.  Interactions of cationic drugs and cardiac glycosides at the hepatic uptake level: studies in the ratin vivo, isolated perfused rat liver, isolated rat hepatocytes and oocytes expressing oatp2 , 2002, Archives of pharmacal research.

[40]  J H Lewis,et al.  Drug-induced liver disease. , 2000, Clinics in liver disease.

[41]  A Ammassari,et al.  Efficacy and tolerability of pravastatin for the treatment of HIV-1 protease inhibitor-associated hyperlipidaemia: a pilot study. , 2000, AIDS.

[42]  R. Green,et al.  Mechanism of indinavir-induced hyperbilirubinemia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[43]  P. Bosma,et al.  Hepatic uptake of organic anions affects the plasma bilirubin level in subjects with Gilbert's syndrome mutations in UGT1A1 , 2001, Hepatology.

[44]  C. Rayner,et al.  Symptomatic Hyperbilirubinemia with Indinavir/Ritonavir—Containing Regimen , 2001, The Annals of pharmacotherapy.

[45]  A. Laupacis,et al.  HYPERBILIRUBINAEMIA AND CYCLOSPORIN A LEVELS , 1981, The Lancet.

[46]  J. Nezu,et al.  Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis. , 2002, The Journal of pharmacology and experimental therapeutics.

[47]  Y. Sugiyama,et al.  Transport of temocaprilat into rat hepatocytes: role of organic anion transporting polypeptide. , 1998, The Journal of pharmacology and experimental therapeutics.